Signal
News Roundup: Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs https://www.biopharmadive.com/news/pfizer-obesity-china-alnylam-tena...
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-03-06 09:48 UTCUpdated 2026-03-06 19:26 UTC
rssx
regulationtenaya_rnai
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (2 domains)domains are deduped. counts indicate coverage, not truth.2 top sources shown
limited source diversity in top sources
Overview
Alnylam bets on Tenaya RNAi tech, and other licensing news Phil.Taylor Fri, 06/03/2026 - 09:48.
Score total
1.27
Momentum 24h
3
Posts
3
Origins
2
Source types
2
Duplicate ratio
33%
All evidence
All evidence
Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs
BioPharma Dive · biopharmadive.com · 2026-03-06 15:13 UTC
Alnylam bets on Tenaya RNAi tech, and other licensing news
pharmaphorum · pharmaphorum.com · 2026-03-06 09:48 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- BioPharma Dive (1)
- pharmaphorum (1)
Top origin domains (this list)
- biopharmadive.com (1)
- pharmaphorum.com (1)